You’re using a public version of DrugPatentWatch with 5 free searches available | Register to unlock more free searches. CREATE FREE ACCOUNT

Last Updated: April 28, 2024

Ferric oxyhydroxide - Generic Drug Details


✉ Email this page to a colleague

« Back to Dashboard


What are the generic sources for ferric oxyhydroxide and what is the scope of patent protection?

Ferric oxyhydroxide is the generic ingredient in eight branded drugs marketed by Am Regent, Sanofi Aventis Us, Allergan, New River, West-ward Pharms Int, and Vifor Fresenius, and is included in eight NDAs. There are eleven patents protecting this compound. Additional information is available in the individual branded drug profile pages.

Ferric oxyhydroxide has one hundred and nineteen patent family members in thirty-five countries.

There are three drug master file entries for ferric oxyhydroxide. Nine suppliers are listed for this compound.

Pharmacology for ferric oxyhydroxide

US Patents and Regulatory Information for ferric oxyhydroxide

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Allergan INFED ferric oxyhydroxide INJECTABLE;INJECTION 017441-001 Approved Prior to Jan 1, 1982 BP RX Yes Yes ⤷  Try a Trial ⤷  Try a Trial ⤷  Try a Trial
New River PROFERDEX ferric oxyhydroxide INJECTABLE;INJECTION 017807-001 Approved Prior to Jan 1, 1982 DISCN No No ⤷  Try a Trial ⤷  Try a Trial ⤷  Try a Trial
Vifor Fresenius VELPHORO ferric oxyhydroxide TABLET, CHEWABLE;ORAL 205109-001 Nov 27, 2013 RX Yes Yes ⤷  Try a Trial ⤷  Try a Trial Y ⤷  Try a Trial
Vifor Fresenius VELPHORO ferric oxyhydroxide TABLET, CHEWABLE;ORAL 205109-001 Nov 27, 2013 RX Yes Yes ⤷  Try a Trial ⤷  Try a Trial Y ⤷  Try a Trial
Sanofi Aventis Us FERRLECIT ferric oxyhydroxide INJECTABLE;INJECTION 020955-001 Feb 18, 1999 AB RX Yes Yes ⤷  Try a Trial ⤷  Try a Trial ⤷  Try a Trial
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

Expired US Patents for ferric oxyhydroxide

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Am Regent DEXFERRUM ferric oxyhydroxide INJECTABLE;INJECTION 040024-001 Feb 23, 1996 ⤷  Try a Trial ⤷  Try a Trial
Vifor Fresenius VELPHORO ferric oxyhydroxide TABLET, CHEWABLE;ORAL 205109-001 Nov 27, 2013 ⤷  Try a Trial ⤷  Try a Trial
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >Patent No. >Patent Expiration

International Patents for ferric oxyhydroxide

Country Patent Number Title Estimated Expiration
Australia 2020217386 Pharmaceutical composition, comprising phosphate binder particles ⤷  Try a Trial
Australia 2022204380 Pharmaceutical composition, comprising phosphate binder particles ⤷  Try a Trial
Colombia 6280398 COMPOSICIONES FARMACEUTICAS QUE CONTIENEN OXIHIDROXIDO DE HIERRO EN ALTA CARGA ⤷  Try a Trial
Portugal 2222285 ⤷  Try a Trial
European Patent Office 3741360 COMPOSITION PHARMACEUTIQUE COMPRENANT DES PARTICULES DE LIANT DU PHOSPHATE (PHARMACEUTICAL COMPOSITION, COMPRISING PHOSPHATE BINDER PARTICLES) ⤷  Try a Trial
>Country >Patent Number >Title >Estimated Expiration

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.